Summarized by Masters of Longevity from PR Newswire.
Randomized trial data show sustained clinical responses and favorable long-term safety.
Key Takeaways
- SetPoint Therapy maintained and often improved ACR responses.
- About half of participants reached low activity or remission.
- No serious device-related adverse events were reported.
